INMUNE BIO INC. Increase (Decrease) in Accounts Receivable
INMUNE BIO INC. (INMB) reported Increase (Decrease) in Accounts Receivable of $129.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-06
- INMUNE BIO INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $3.93M, a 1121.74% increase year-over-year.
- INMUNE BIO INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$3.81M, a 3830.39% decline year-over-year.
- INMUNE BIO INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $2.58M, a 3483.33% increase year-over-year.
- INMUNE BIO INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $99.00K.
- INMUNE BIO INC. increase (decrease) in accounts receivable for fiscal 2025 was $3.10M.
- INMUNE BIO INC. increase (decrease) in accounts receivable for fiscal 2024 was -$724.00K.
- INMUNE BIO INC. increase (decrease) in accounts receivable for fiscal 2023 was -$6.19M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $129.00K 10-Q · filed 2026-08-06 | $2.71M derived: sum of 3 quarters · filed 2026-08-06 | $2.81M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$3.81M 10-Q · filed 2026-05-07 | -$1.23M derived: sum of 2 quarters · filed 2026-05-07 | -$1.13M derived: sum of 3 quarters · filed 2026-05-07 | -$804.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $2.68M derived: sum of 2 quarters · filed 2026-03-30 | $3.00M derived: sum of 3 quarters · filed 2026-08-06 | $3.10M 10-K · filed 2026-03-30 |
| 2025-09-30 | $99.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $421.00K derived: sum of 2 quarters · filed 2026-08-06 | $523.00K 10-Q · filed 2025-10-30 | $595.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $322.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $424.00K 10-Q · filed 2026-08-06 | $496.00K derived: sum of 3 quarters · filed 2026-08-06 | -$1.54M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $102.00K 10-Q · filed 2026-05-07 | $174.00K derived: sum of 2 quarters · filed 2026-05-07 | -$1.86M derived: sum of 3 quarters · filed 2026-05-07 | -$850.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $72.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$1.96M derived: sum of 2 quarters · filed 2026-03-30 | -$952.00K derived: sum of 3 quarters · filed 2026-03-30 | -$724.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | -$2.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$1.02M derived: sum of 2 quarters · filed 2025-10-30 | -$796.00K 10-Q · filed 2025-10-30 | -$978.00K derived: sum of 4 quarters · filed 2025-10-30 |
| 2024-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.24M 10-Q · filed 2025-08-07 | $1.06M derived: sum of 3 quarters · filed 2025-08-07 | $1.21M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $228.00K 10-Q · filed 2025-05-08 | $46.00K derived: sum of 2 quarters · filed 2025-05-08 | $199.00K derived: sum of 3 quarters · filed 2025-05-08 | |
| 2023-12-31 | -$182.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$29.00K derived: sum of 2 quarters · filed 2025-03-27 | -$6.19M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $153.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$6.01M 10-Q · filed 2024-10-31 | ||
| 2023-06-30 | -$6.17M 10-Q · filed 2024-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |